Leningrad Regional Oncology Center — Saint Petersburg

Which of these are you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near Saint Petersburg →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of Leningrad Regional Oncology Center, compiled from the ClinicalTrials.gov public registry.

23

Registered studies

1

Active

18

Completed

1

Stopped or withdrawn

Most-studied conditions

Breast Cancer With Low to Intermediate HER2 Expression · Squamous Cell Carcinoma of the Oral Cavity · Urinary Bladder Cancer, Muscle-invasive · Locally Advanced Pancreatic Cancer

Recently updated registry entries

NCT03924856 — Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative… (Completed)
NCT03924895 — Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus… (Active Not Recruiting)
NCT03797326 — Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in… (Completed)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.